Women's health is one of the hottest categories in health tech right now, and the reasons are real. The FDA's move to pull the boxed warning from menopausal hormone therapy reopened a conversation that had been closed for twenty years. Perimenopause and menopause are being discussed in public in a way they never were. A large population of women in midlife cannot get answers from the care they have, either because they live somewhere without access to specialists or because they keep hitting walls with the providers they see. Telehealth platforms that put those women in front of a hormone specialist are filling a gap that should have been filled a long time ago.
I've operated alongside these vendors as they've come up, and they are getting traction. Members are going to the site, booking a visit, and paying for it. The question for an investor is what happens after that, because the growth model in most of these decks depends on a payer channel the company hasn't built.
What does "we work with insurance" actually mean?
Read the fine print on the platform's site. "We accept insurance" tends to mean one of three things. The platform is contracted with a handful of large carriers, so a member on one of those fully insured plans may be covered and everyone else is not. Or the platform will give the member a superbill to submit on their own, which is a cash-pay business with a document attached. Or the platform submits a claim, but as an out-of-network provider, so it pays at the out-of-network benefit or not at all.
For most people with employer coverage, that last case is the one that applies. The majority of workers with employer plans are in self-funded plans, where the employer pays the claims and a TPA administers them. A platform that is "in network" with a carrier is not necessarily in network with the self-funded plan that carrier's network serves, and a platform with no arrangement at all is simply out of network or non-covered based on that status. The member finds this out when the claim comes back.
So the member is paying premiums, paying the platform in cash, and then being told a service their plan would have covered through their OB/GYN is not covered through the platform. With the average family premium now around $26,000 a year, another out-of-pocket healthcare cost is where consumers freeze. That is the ceiling on a cash-pay model, and it is lower than the deck implies.
Where is the market these platforms are skipping?
The services these platforms deliver, a visit with a prescriber and the medication that follows, are typically covered benefits under the health plan already. The platform is not asking the plan to cover something new. It is asking to be the place the member gets something the plan already pays for. That is a much easier sale than a new benefit, and most of these companies are not making it.
Selling self-funded plans one employer at a time is whack-a-mole, and I understand why founders avoid it. The channel that scales is the TPA. A platform that partners with a TPA, especially a tech-enabled one, becomes an option across every plan that TPA administers. The mechanics are not exotic: a claims feed by EDI or SFTP so a visit becomes a clean claim the TPA adjudicates, a fixed fee schedule that is simple enough to drop into the plan's underwriting and strict enough to prove savings against the alternative, and a preferred-platform arrangement so the TPA's account managers know to point members there.
That setup turns a cash expense on top of premiums into a covered benefit a member can use without reaching into her own pocket, and it puts the platform in front of an entire covered population at once instead of one paying customer at a time. The platforms that build it will own the category. The ones that don't will stay boutiques with a national ad budget.
Do they understand the swim lanes?
This is the part I see from the operator's side, and it's where even a well-run platform creates work for everyone downstream. A member has a visit. The prescriber writes for hormone therapy. The platform then produces an itemized bill for the visit and the medication and hands it to the member to submit to her insurance.
That is the wrong path. A visit is a medical claim. A prescription is a pharmacy claim. The prescription doesn't need to be submitted anywhere by the member; it needs to be sent to her pharmacy, where it runs through the pharmacy benefit and is covered or not on the spot. Handing the member a bill for the prescription to submit to the medical plan sends her on a chase: the TPA denies it as a pharmacy item, the PBM has never seen it, the member calls HR, and HR calls the TPA.
The same thing happens when the platform submits on the member's behalf and sends the medical and pharmacy items to the same place. These platforms have not taken the time to learn how reimbursement actually moves between the medical payer, the PBM, and the pharmacy, and the member pays for that in frustration. The platform rarely sees it, because the complaint lands at the TPA.
For an investor, the swim lanes are a proxy for something larger. A company that routes a prescription to the wrong lane does not yet have anyone on the team who has worked inside a payer, and that is the hire that decides whether the TPA channel above is possible. Brilliant clinical and technical founders build the product and keep the payer side thin because they don't know enough to interview for it. Ask who on the team has run claims, benefits, or network operations. If the answer is a consultant they talked to once, price that in.
What should be in the data room?
Revenue split: cash-pay, paid by a carrier under contract, paid by a self-funded plan through a TPA. With the carrier and TPA list and the terms of each.
The claims path: whether the platform submits claims, as what network status, by what feed, and the denial and out-of-network rates on them.
The fee schedule, if one exists, and whether any TPA or plan has accepted it into underwriting.
How prescriptions are routed: to the member's pharmacy through the pharmacy benefit, or to the member as a bill. The volume of reimbursement issues the support team handles.
Who on the team has operated inside a TPA, carrier, or PBM, and what they own.
Member acquisition cost against lifetime value under the cash model, and the model's assumptions about insurance coverage that have not yet been contracted.
Is any of this a reason to pass?
No. This is a profound service. It gives women access to specialists they cannot find where they live and answers they were not getting from the care they had. The demand is real and the clinical need is real.
What's missing in most of these companies is the sales channel and the operating knowledge to use it. A founder who can explain why the TPA is the channel, what a claims feed and a fixed fee schedule do for the plan's underwriting, and why a prescription goes to the pharmacy and not to the member, is running a company that can reach the whole market. A founder with a smooth answer about "working with insurance" is running a cash-pay business with a growth slide. That is a finding, and it should change the allocation toward the payer operations layer, the projections, or the decision.